RIPK3 and neoplasm: Also, similarly to what was observed for MLKL, we have previously shown that higher RIPK3 expression is associated with worse prognosis in diffuse glioma patients [27], suggesting that increased sensitivity to necroptosis may be also relevant to tumor progression.